RxAll, a Yale-founded startup, has developed an AI-powered device that can accurately detect counterfeit drugs within seconds, saving lives and improving healthcare outcomes globally.
 |
| A team of Yale University graduates has developed an AI-powered device that can accurately identify counterfeit drugs within seconds, offering a potential solution to the global health crisis. Symbolic image |
New Haven, CT – September 04, 2024:
A group of Yale University graduates have developed an innovative AI-powered device that could revolutionize the fight against counterfeit drugs. RxAll, a healthcare startup founded by Adebayo Alonge, Amy Kao, and Wei Lui in 2016, aims to address the global issue of fake medications that have led to countless deaths and illnesses.
Inspired by their own personal experiences with counterfeit drugs, the founders recognized the urgent need for a solution. Alonge narrowly escaped death after taking a medication containing a dangerous amount of diazepam, while Kao was hospitalized after consuming counterfeit medicine. Wei, too, had lost a family member to contaminated drugs.
Their research and development efforts led to the creation of RxScanner, a device capable of authenticating medicine within 20 seconds. Powered by artificial intelligence and machine learning, RxScanner can accurately identify over 300 drug types with a 99.9% success rate. The device has been deployed in 15 countries and has helped over 500,000 people.
Beyond drug authentication, RxAll has expanded its services to include a drug delivery platform for 3 million patients in Kenya, Nigeria, and Uganda. The company is also working to improve drug affordability and accessibility through a marketplace for pharmacies and wholesalers.
"Our vision has evolved," Alonge stated. "We're now committed to raising healthcare standards across Africa."
RxAll's growth has been fueled by a dedicated team of 50 employees and significant funding. The company has raised $3.15 million in seed and pre-seed funding and is currently seeking additional capital to expand its operations in Asia.
The founders' personal experiences have been a driving force behind their work. "Knowing that we can prevent even one person from going through the trauma we've endured is incredibly motivating," Kao explained.
As RxAll continues to make strides in combating counterfeit drugs, its innovative technology holds the promise of saving countless lives and improving healthcare outcomes worldwide.